Robert Lisicki

Insider Reports History

Location
San Diego, CA
Signature
/s/ Robert Lisicki
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Lisicki:

Form 4 holding Chief Executive Officer, Director

Zura Bio Ltd

Security class
Employee Share Option (Right to Buy)
Shares / value
1,153,000
Estimated value
Report date
27 Feb 2025
Price
Ownership
Direct
Underlying class
Class A Ordinary Shares
Underlying amount
Form 4 holding Director

Cadrenal Therapeutics, Inc.

Security class
Stock Options
Shares / value
20,000
Estimated value
Report date
23 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP, Chief Commercial Officer

ARENA PHARMACEUTICALS INC

Security class
Common Stock
Shares / value
0
Estimated value
Report date
11 Mar 2022
Price
$98.51
Ownership
Direct
Form 4 holding EVP, Chief Commercial Officer

ARENA PHARMACEUTICALS INC

Security class
Employee Performance Restricted Stock Unit
Shares / value
0
Estimated value
Report date
11 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP, Chief Commercial Officer

ARENA PHARMACEUTICALS INC

Security class
Employee Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
11 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Robert Lisicki

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .